Exicure XCUR
NASDAQ XCUR
$1.23 +0.09 (+7.89%)
As of: Sep 30, 2026 · 10:07 AM EDT

Exicure (XCUR) Notes Payables (2017)

Updated

Exicure's Notes Payables came in at $24,600 for Q3 2017.

Analysis

Exicure (XCUR) Notes Payables (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Exicure 7.90 Mn 7.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2017 24,600.00
API Access

Exicure Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=XCUR&period=max&api_key=YOUR_API_KEY